Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease
Seminars in Liver Disease · 01.05.2023 · 43 (02) · 226-233
DOI: 10.1055/a-2104-9034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Liver Disease, erschienen am 01.05.2023. Verfasst von Jessica K Bernard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Cholestasis, Liver Cirrhosis, Biliary. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University, the Indiana University Health - Indiana University School of Medicine Strategic Research…, United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service, Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University, the Indiana University Health – Indiana University School of Medicine Strategic Research….
Abstract (Originalsprache)
Mast cells (MCs) contribute to the pathogenesis of cholestatic liver diseases (primary sclerosing cholangitis [PSC] and primary biliary cholangitis [PBC]). PSC and PBC are immune-mediated, chronic inflammatory diseases, characterized by bile duct inflammation and stricturing, advancing to hepatobiliary cirrhosis. MCs are tissue resident immune cells that may promote hepatic injury, inflammation, and fibrosis formation by either direct or indirect interactions with other innate immune cells (neutrophils, macrophages/Kupffer cells, dendritic cells, natural killer, and innate lymphoid cells). The activation of these innate immune cells, usually through the degranulation of MCs, promotes antigen uptake and presentation to adaptive immune cells, exacerbating liver injury. In conclusion, dysregulation of MC-innate immune cell communications during liver injury and inflammation can lead to chronic liver injury and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
- Department of Research, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.
Förderung
- Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University, the Indiana University Health - Indiana University School of Medicine Strategic Research…
- United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service
- Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University, the Indiana University Health – Indiana University School of Medicine Strategic Research…
Zitieren
APA
Bernard, J. K., Marakovits, C., Smith, L. G., & Francis, H. (2023). Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease. Seminars in Liver Disease, 43(02), 226-233. https://doi.org/10.1055/a-2104-9034
Vancouver
Bernard JK, Marakovits C, Smith LG, Francis H. Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease. Seminars in Liver Disease. 2023;43(02):226-233. doi:10.1055/a-2104-9034
BibTeX
@article{Bernard2023,
author = {Bernard, Jessica K and Marakovits, Corinn and Smith, Leah G and Francis, Heather},
title = {Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease},
journal = {Seminars in Liver Disease},
year = {2023},
volume = {43},
number = {02},
pages = {226--233},
doi = {10.1055/a-2104-9034}
}
EUVIMED